The Roche Diagnostics AmpliChip microarray product will have not one, but several hurdles to cross before it can gain a seal of approval from the US Food and Drug Administration.

The microarray-based product, designed by Roche, and manufactured by Affymetrix, will have to gain FDA approval as an in vitro diagnostic device, and, according to Janet Woodcock, director for the Center for Drug Evaluation & Research of the FDA, the agency will have to validate the data the device provides — for each test it performs.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.